BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8156832)

  • 1. [Assessment of the therapeutic effect in acute myelogenous leukemia].
    Pu Q
    Zhonghua Nei Ke Za Zhi; 1993 Oct; 32(10):653-5. PubMed ID: 8156832
    [No Abstract]   [Full Text] [Related]  

  • 2. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
    Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
    Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
    [No Abstract]   [Full Text] [Related]  

  • 3. Interrupting the inhibiton of normal hematopoiesis in myelogenous leukemia: a hypothetical approach to therapy.
    Lichtman MA
    Stem Cells; 2000; 18(5):304-6. PubMed ID: 11007914
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modern strategies in therapy of acute myeloid leukemia (AML) in adulthood. I. Primary treatment of de novo AML].
    Jehn U; Dengler R; Petrides PE
    Internist (Berl); 1996 Jun; 37(6):661-8. PubMed ID: 8768003
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of acute myelogenous leukemia. A review.
    Zittoun R
    Leukemia; 1992; 6 Suppl 2():36-8. PubMed ID: 1578939
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myeloid leukemia presenting with a uterus tumor.
    Albrecht O; Serve H; Tchinda J; Zühlsdorf M; Büchner T; Bremer C; Parwaresch R; Berdel WE
    Ann Hematol; 2006 Jan; 85(1):58-9. PubMed ID: 16237527
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy versus transplantation: I. Acute myelogenous leukemia.
    Gale RP; Butturini A
    Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathomorphosis of acute leukemia].
    Popov VM
    Sov Med; 1991; (9):15-8. PubMed ID: 1724709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia.
    Preisler HD; Raza A; Kukla C; Larson R; Goldberg J; Browman G
    Blood; 1991 Aug; 78(3):849-50. PubMed ID: 1859896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostics and therapy of acute myeloid leukemia].
    Kern W; Haferlach T; Schoch C; Hiddemann W
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2208-13. PubMed ID: 12397550
    [No Abstract]   [Full Text] [Related]  

  • 11. Current chemotherapeutic treatment approaches to the management of previously untreated adults with de novo acute myelogenous leukemia.
    Mayer RJ
    Semin Oncol; 1987 Dec; 14(4):384-96. PubMed ID: 3321443
    [No Abstract]   [Full Text] [Related]  

  • 12. The Leser-Trelat sign is a associated with acute myeloid leukemia.
    Yavasoglu I; Kadikoylu G; Bolaman Z
    Ann Hematol; 2011 Mar; 90(3):363. PubMed ID: 20703879
    [No Abstract]   [Full Text] [Related]  

  • 13. [A histopathological study of bone marrow following chemotherapy of acute myeloid leukemia].
    Pu Q
    Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):431-3, 30. PubMed ID: 1660761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and therapeutic implications of early treatment response assessment in acute myeloid leukemia.
    Pullarkat V; Aldoss I
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):38-45. PubMed ID: 25624175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
    Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
    Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the myelogram carried out on the 6th day of remission- inducing treatment of acute nonlymphoblastic leukemia in adults as an indicator of therapeutic effectiveness].
    Kniewska I; Hołowiecki J; Krykowski E; Rudzka E; Krzemień S; Krawczyk M; Duraj M; Brodowski L; Urbańska-Ryś H
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):872-4. PubMed ID: 2487940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of adult acute myelogenous leukemia: a pilot study at Chulalongkorn Hospital.
    Intragumtornchai T; Sucharitchan P; Swasdikul D; Mahasandhana S; Watananukul P
    J Med Assoc Thai; 1991 Jul; 74(7):265-71. PubMed ID: 1765741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the proliferative index of residual leukemia with outcome in patients treated with sequential high dose ara-C and asparaginase.
    Powell BL; Kute TE; Craig JB; Lyerly ES; Gregory BW; Do KA; Contento MM; Capizzi RL
    Leukemia; 1990 May; 4(5):316-20. PubMed ID: 2388477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of cultured bone marrow cells for autologous transplantation in patients with acute myeloblastic leukemia.
    Testa NG; Coutinho L; Chang J; Morgenstern G; Scarffe JH; Dexter TM
    Haematol Blood Transfus; 1987; 31():75-8. PubMed ID: 3327789
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report.
    Vogler WR; Raney MR
    Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.